Gary Hennerberg
Direktor/Vorstandsmitglied bei BIOREGENX, INC.
Vermögen: 525 955 $ am 31.05.2024
Profil
Gary Hennerberg is currently working as the Secretary & Director at BioRegenx, Inc. He previously worked at BioRegenx, Inc. as the Chief Marketing Officer & Director.
He completed his undergraduate degree at Fort Hays State University in 1978.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOREGENX INC
1,72% | 08.03.2024 | 16 436 000 ( 1,72% ) | 525 952 $ | 31.05.2024 |
FINDIT INC PFD A
0,00% | 08.03.2024 | 108 ( 0,00% ) | 3 $ | 31.05.2024 |
Aktive Positionen von Gary Hennerberg
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOREGENX, INC. | Direktor/Vorstandsmitglied | 08.03.2024 |
Ehemalige bekannte Positionen von Gary Hennerberg
| Unternehmen | Position | Ende |
|---|---|---|
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Direktor/Vorstandsmitglied | - |
Ausbildung von Gary Hennerberg
| Fort Hays State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
| Findit, Inc. |
